1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	Mediterranean	_	_	JJ	_	_	_	_	_
3	diet	_	_	NN	_	_	_	_	_
4	(	_	_	-LRB-	_	_	_	_	_
5	MD	_	_	NNP	_	_	_	_	_
6	)	_	_	-RRB-	_	_	_	_	_
7	has	_	_	VBZ	_	_	_	_	_
8	been	_	_	VBN	_	_	_	_	_
9	recognized	_	_	VBN	_	_	_	_	_
10	as	_	_	IN	_	_	_	_	_
11	a	_	_	DT	_	_	_	_	_
12	model	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	healthy	_	_	JJ	_	_	_	_	_
15	eating	_	_	NN	_	_	_	_	_
16	because	_	_	IN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	its	_	_	PRP$	_	_	_	_	_
19	contribution	_	_	NN	_	_	_	_	_
20	to	_	_	TO	_	_	_	_	_
21	a	_	_	DT	_	_	_	_	_
22	healthy	_	_	JJ	_	_	_	_	_
23	lifestyle	_	_	NN	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	a	_	_	DT	_	_	_	_	_
26	better	_	_	JJR	_	_	_	_	_
27	quality	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	life	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	MD	_	_	NNP	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	much	_	_	RB	_	_	_	_	_
5	more	_	_	JJR	_	_	_	_	_
6	than	_	_	IN	_	_	_	_	_
7	a	_	_	DT	_	_	_	_	_
8	dietary	_	_	JJ	_	_	_	_	_
9	pattern	_	_	NN	_	_	_	_	_
10	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	word	_	_	NN	_	_	_	_	_
3	diet	_	_	NN	_	_	_	_	_
4	comes	_	_	VBZ	_	_	_	_	_
5	from	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	Greek	_	_	JJ	_	_	_	_	_
8	diaita	_	_	NN	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	means	_	_	VBZ	_	_	_	_	_
11	‘	_	_	``	_	_	_	_	_
12	way	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	life	_	_	NN	_	_	_	_	_
15	’	_	_	''	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	MD	_	_	NNP	_	_	_	_	_
19	holds	_	_	VBZ	_	_	_	_	_
20	true	_	_	JJ	_	_	_	_	_
21	to	_	_	TO	_	_	_	_	_
22	this	_	_	DT	_	_	_	_	_
23	meaning	_	_	NN	_	_	_	_	_
24	as	_	_	IN	_	_	_	_	_
25	MD	_	_	NNP	_	_	_	_	_
26	covers	_	_	VBZ	_	_	_	_	_
27	not	_	_	RB	_	_	_	_	_
28	only	_	_	RB	_	_	_	_	_
29	what	_	_	WP	_	_	_	_	_
30	to	_	_	TO	_	_	_	_	_
31	eat	_	_	VB	_	_	_	_	_
32	but	_	_	CC	_	_	_	_	_
33	how	_	_	WRB	_	_	_	_	_
34	to	_	_	TO	_	_	_	_	_
35	eat	_	_	VB	_	_	_	_	_
36	and	_	_	CC	_	_	_	_	_
37	live	_	_	VB	_	_	_	_	_
38	(	_	_	-LRB-	_	_	_	_	_
39	active	_	_	JJ	_	_	_	_	_
40	lifestyle	_	_	NN	_	_	_	_	_
41	,	_	_	,	_	_	_	_	_
42	prioritizing	_	_	VBG	_	_	_	_	_
43	culinary	_	_	JJ	_	_	_	_	_
44	activities	_	_	NNS	_	_	_	_	_
45	,	_	_	,	_	_	_	_	_
46	etc.	_	_	FW	_	_	_	_	_
47	)	_	_	-RRB-	_	_	_	_	_
48	.	_	_	.	_	_	_	_	_


1	And	_	_	CC	_	_	_	_	_
2	it	_	_	PRP	_	_	_	_	_
3	should	_	_	MD	_	_	_	_	_
4	be	_	_	VB	_	_	_	_	_
5	preserved	_	_	VBN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	Mediterranean	_	_	JJ	_	_	_	_	_
9	basin	_	_	NN	_	_	_	_	_
10	where	_	_	WRB	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	past	_	_	JJ	_	_	_	_	_
15	decades	_	_	NNS	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	dietary	_	_	JJ	_	_	_	_	_
18	trends	_	_	NNS	_	_	_	_	_
19	are	_	_	VBP	_	_	_	_	_
20	departing	_	_	VBG	_	_	_	_	_
21	from	_	_	IN	_	_	_	_	_
22	traditional	_	_	JJ	_	_	_	_	_
23	dietary	_	_	JJ	_	_	_	_	_
24	patterns	_	_	NNS	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	principles	_	_	NNS	_	_	_	_	_
3	underlying	_	_	VBG	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	MD	_	_	NNP	_	_	_	_	_
6	—	_	_	:	_	_	_	_	_
7	widely	_	_	RB	_	_	_	_	_
8	documented	_	_	VBN	_	_	_	_	_
9	elsewhere	_	_	RB	_	_	_	_	_
10	—	_	_	:	_	_	_	_	_
11	can	_	_	MD	_	_	_	_	_
12	be	_	_	VB	_	_	_	_	_
13	summarized	_	_	VBN	_	_	_	_	_
14	as	_	_	IN	_	_	_	_	_
15	follows	_	_	VBZ	_	_	_	_	_
16	:	_	_	:	_	_	_	_	_


1	high	_	_	JJ	_	_	_	_	_
2	consumption	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	fruits	_	_	NNS	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	vegetables	_	_	NNS	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	cereals	_	_	NNS	_	_	_	_	_
9	(	_	_	-LRB-	_	_	_	_	_
10	especially	_	_	RB	_	_	_	_	_
11	whole	_	_	JJ	_	_	_	_	_
12	seeds	_	_	NNS	_	_	_	_	_
13	)	_	_	-RRB-	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	legumes	_	_	NNS	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	nuts	_	_	NNS	_	_	_	_	_
19	;	_	_	:	_	_	_	_	_
20	relatively	_	_	RB	_	_	_	_	_
21	high	_	_	JJ	_	_	_	_	_
22	fat	_	_	NN	_	_	_	_	_
23	consumption	_	_	NN	_	_	_	_	_
24	(	_	_	-LRB-	_	_	_	_	_
25	up	_	_	IN	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	40	_	_	CD	_	_	_	_	_
28	%	_	_	NN	_	_	_	_	_
29	of	_	_	IN	_	_	_	_	_
30	total	_	_	JJ	_	_	_	_	_
31	energy	_	_	NN	_	_	_	_	_
32	intake	_	_	NN	_	_	_	_	_
33	)	_	_	-RRB-	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	mainly	_	_	RB	_	_	_	_	_
36	monounsaturated	_	_	JJ	_	_	_	_	_
37	fatty	_	_	NN	_	_	_	_	_
38	acids	_	_	NNS	_	_	_	_	_
39	(	_	_	-LRB-	_	_	_	_	_
40	MUFAs	_	_	NNP	_	_	_	_	_
41	)	_	_	-RRB-	_	_	_	_	_
42	from	_	_	IN	_	_	_	_	_
43	extra-virgin	_	_	JJ	_	_	_	_	_
44	olive	_	_	NN	_	_	_	_	_
45	oil	_	_	NN	_	_	_	_	_
46	,	_	_	,	_	_	_	_	_
47	the	_	_	DT	_	_	_	_	_
48	main	_	_	JJ	_	_	_	_	_
49	fat	_	_	NN	_	_	_	_	_
50	used	_	_	VBN	_	_	_	_	_
51	for	_	_	IN	_	_	_	_	_
52	seasoning	_	_	NN	_	_	_	_	_
53	and	_	_	CC	_	_	_	_	_
54	cooking	_	_	NN	_	_	_	_	_
55	;	_	_	:	_	_	_	_	_
56	moderate	_	_	JJ	_	_	_	_	_
57	to	_	_	TO	_	_	_	_	_
58	high	_	_	JJ	_	_	_	_	_
59	consumption	_	_	NN	_	_	_	_	_
60	of	_	_	IN	_	_	_	_	_
61	fish	_	_	NN	_	_	_	_	_
62	;	_	_	:	_	_	_	_	_
63	moderate	_	_	JJ	_	_	_	_	_
64	dairy	_	_	NN	_	_	_	_	_
65	product	_	_	NN	_	_	_	_	_
66	consumption	_	_	NN	_	_	_	_	_
67	,	_	_	,	_	_	_	_	_
68	usually	_	_	RB	_	_	_	_	_
69	in	_	_	IN	_	_	_	_	_
70	the	_	_	DT	_	_	_	_	_
71	form	_	_	NN	_	_	_	_	_
72	of	_	_	IN	_	_	_	_	_
73	yogurt	_	_	NN	_	_	_	_	_
74	and	_	_	CC	_	_	_	_	_
75	cheese	_	_	NN	_	_	_	_	_
76	;	_	_	:	_	_	_	_	_
77	low	_	_	JJ	_	_	_	_	_
78	red	_	_	JJ	_	_	_	_	_
79	meat	_	_	NN	_	_	_	_	_
80	and	_	_	CC	_	_	_	_	_
81	meat	_	_	NN	_	_	_	_	_
82	product	_	_	NN	_	_	_	_	_
83	consumption	_	_	NN	_	_	_	_	_
84	;	_	_	:	_	_	_	_	_
85	moderate	_	_	JJ	_	_	_	_	_
86	alcohol	_	_	NN	_	_	_	_	_
87	consumption	_	_	NN	_	_	_	_	_
88	,	_	_	,	_	_	_	_	_
89	mainly	_	_	RB	_	_	_	_	_
90	in	_	_	IN	_	_	_	_	_
91	the	_	_	DT	_	_	_	_	_
92	form	_	_	NN	_	_	_	_	_
93	of	_	_	IN	_	_	_	_	_
94	red	_	_	JJ	_	_	_	_	_
95	wine	_	_	NN	_	_	_	_	_
96	during	_	_	IN	_	_	_	_	_
97	meals	_	_	NNS	_	_	_	_	_
98	;	_	_	:	_	_	_	_	_
99	low	_	_	JJ	_	_	_	_	_
100	consumption	_	_	NN	_	_	_	_	_
101	of	_	_	IN	_	_	_	_	_
102	simple	_	_	JJ	_	_	_	_	_
103	sugars	_	_	NNS	_	_	_	_	_
104	(	_	_	-LRB-	_	_	_	_	_
105	pastries	_	_	NNS	_	_	_	_	_
106	,	_	_	,	_	_	_	_	_
107	soft	_	_	JJ	_	_	_	_	_
108	drinks	_	_	NNS	_	_	_	_	_
109	,	_	_	,	_	_	_	_	_
110	etc.	_	_	FW	_	_	_	_	_
111	)	_	_	-RRB-	_	_	_	_	_
112	;	_	_	:	_	_	_	_	_
113	and	_	_	CC	_	_	_	_	_
114	high	_	_	JJ	_	_	_	_	_
115	consumption	_	_	NN	_	_	_	_	_
116	of	_	_	IN	_	_	_	_	_
117	herbs	_	_	NNS	_	_	_	_	_
118	and	_	_	CC	_	_	_	_	_
119	spices	_	_	NNS	_	_	_	_	_
120	—	_	_	:	_	_	_	_	_
121	an	_	_	DT	_	_	_	_	_
122	important	_	_	JJ	_	_	_	_	_
123	source	_	_	NN	_	_	_	_	_
124	of	_	_	IN	_	_	_	_	_
125	micronutrients	_	_	NNS	_	_	_	_	_
126	,	_	_	,	_	_	_	_	_
127	including	_	_	VBG	_	_	_	_	_
128	calcium	_	_	NN	_	_	_	_	_
129	(	_	_	-LRB-	_	_	_	_	_
130	Ca	_	_	NN	_	_	_	_	_
131	)	_	_	-RRB-	_	_	_	_	_
132	—	_	_	:	_	_	_	_	_
133	used	_	_	VBN	_	_	_	_	_
134	to	_	_	TO	_	_	_	_	_
135	flavor	_	_	VB	_	_	_	_	_
136	dishes	_	_	NNS	_	_	_	_	_
137	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	traditional	_	_	JJ	_	_	_	_	_
3	diet	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	however	_	_	RB	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	has	_	_	VBZ	_	_	_	_	_
8	been	_	_	VBN	_	_	_	_	_
9	affected	_	_	VBN	_	_	_	_	_
10	by	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	onslaught	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	dietary	_	_	JJ	_	_	_	_	_
15	trends	_	_	NNS	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	recent	_	_	JJ	_	_	_	_	_
18	decades	_	_	NNS	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	Osteoporosis	_	_	NN	_	_	_	_	_
2	(	_	_	-LRB-	_	_	_	_	_
3	OP	_	_	NN	_	_	_	_	_
4	)	_	_	-RRB-	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	among	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	diseases	_	_	NNS	_	_	_	_	_
9	with	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	highest	_	_	JJS	_	_	_	_	_
12	incidence	_	_	NN	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	advanced	_	_	JJ	_	_	_	_	_
15	age	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	i.	_	_	FW	_	_	_	_	_
18	e.	_	_	FW	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	coronary	_	_	JJ	_	_	_	_	_
21	heart	_	_	NN	_	_	_	_	_
22	diseases	_	_	NNS	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	cancer	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	respiratory	_	_	JJ	_	_	_	_	_
27	system	_	_	NN	_	_	_	_	_
28	diseases	_	_	NNS	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	depression	_	_	NN	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	neurodegenerative	_	_	JJ	_	_	_	_	_
34	diseases	_	_	NNS	_	_	_	_	_
35	such	_	_	JJ	_	_	_	_	_
36	as	_	_	IN	_	_	_	_	_
37	Alzheimer	_	_	NNP	_	_	_	_	_
38	’s	_	_	POS	_	_	_	_	_
39	disease	_	_	NN	_	_	_	_	_
40	.	_	_	.	_	_	_	_	_


1	Associated	_	_	VBN	_	_	_	_	_
2	with	_	_	IN	_	_	_	_	_
3	OP	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	especially	_	_	RB	_	_	_	_	_
6	prevalent	_	_	JJ	_	_	_	_	_
7	among	_	_	IN	_	_	_	_	_
8	older	_	_	JJR	_	_	_	_	_
9	women	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	is	_	_	VBZ	_	_	_	_	_
12	bone	_	_	NN	_	_	_	_	_
13	fracture	_	_	NN	_	_	_	_	_
14	risk	_	_	NN	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	growing	_	_	VBG	_	_	_	_	_
3	global	_	_	JJ	_	_	_	_	_
4	health	_	_	NN	_	_	_	_	_
5	problem	_	_	NN	_	_	_	_	_
6	suggests	_	_	VBZ	_	_	_	_	_
7	that	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	prevention	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	OP	_	_	NN	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	its	_	_	PRP$	_	_	_	_	_
14	complications	_	_	NNS	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	maintenance	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	bone	_	_	NN	_	_	_	_	_
20	mass	_	_	NN	_	_	_	_	_
21	are	_	_	VBP	_	_	_	_	_
22	public	_	_	JJ	_	_	_	_	_
23	health	_	_	NN	_	_	_	_	_
24	concerns	_	_	NNS	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	OP	_	_	NNP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	systemic	_	_	JJ	_	_	_	_	_
5	disease	_	_	NN	_	_	_	_	_
6	characterized	_	_	VBN	_	_	_	_	_
7	by	_	_	IN	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	low	_	_	JJ	_	_	_	_	_
10	bone	_	_	NN	_	_	_	_	_
11	mass	_	_	NN	_	_	_	_	_
12	index	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	destruction	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	microarchitecture	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	bone	_	_	NN	_	_	_	_	_
20	mass	_	_	NN	_	_	_	_	_
21	—	_	_	:	_	_	_	_	_
22	i.	_	_	FW	_	_	_	_	_
23	e.	_	_	FW	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	bone	_	_	NN	_	_	_	_	_
26	mineral	_	_	NN	_	_	_	_	_
27	density	_	_	NN	_	_	_	_	_
28	(	_	_	-LRB-	_	_	_	_	_
29	BMD	_	_	NN	_	_	_	_	_
30	)	_	_	-RRB-	_	_	_	_	_
31	—	_	_	:	_	_	_	_	_
32	posing	_	_	VBG	_	_	_	_	_
33	a	_	_	DT	_	_	_	_	_
34	major	_	_	JJ	_	_	_	_	_
35	risk	_	_	NN	_	_	_	_	_
36	of	_	_	IN	_	_	_	_	_
37	fractures	_	_	NNS	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	There	_	_	EX	_	_	_	_	_
2	are	_	_	VBP	_	_	_	_	_
3	no	_	_	DT	_	_	_	_	_
4	symptoms	_	_	NNS	_	_	_	_	_
5	indicating	_	_	VBG	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	reduction	_	_	NN	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	bone	_	_	NN	_	_	_	_	_
10	mass	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	fractures	_	_	NNS	_	_	_	_	_
14	are	_	_	VBP	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	only	_	_	JJ	_	_	_	_	_
17	clinical	_	_	JJ	_	_	_	_	_
18	consequences	_	_	NNS	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	OP	_	_	NN	_	_	_	_	_
21	;	_	_	:	_	_	_	_	_
22	therefore	_	_	RB	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	despite	_	_	IN	_	_	_	_	_
25	being	_	_	VBG	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	most	_	_	RBS	_	_	_	_	_
28	common	_	_	JJ	_	_	_	_	_
29	bone	_	_	NN	_	_	_	_	_
30	disease	_	_	NN	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	the	_	_	DT	_	_	_	_	_
33	incidence	_	_	NN	_	_	_	_	_
34	is	_	_	VBZ	_	_	_	_	_
35	difficult	_	_	JJ	_	_	_	_	_
36	to	_	_	TO	_	_	_	_	_
37	establish	_	_	VB	_	_	_	_	_
38	,	_	_	,	_	_	_	_	_
39	and	_	_	CC	_	_	_	_	_
40	the	_	_	DT	_	_	_	_	_
41	prevalence	_	_	NN	_	_	_	_	_
42	is	_	_	VBZ	_	_	_	_	_
43	often	_	_	RB	_	_	_	_	_
44	based	_	_	VBN	_	_	_	_	_
45	on	_	_	IN	_	_	_	_	_
46	estimates	_	_	NNS	_	_	_	_	_
47	using	_	_	VBG	_	_	_	_	_
48	indirect	_	_	JJ	_	_	_	_	_
49	indicators	_	_	NNS	_	_	_	_	_
50	such	_	_	JJ	_	_	_	_	_
51	as	_	_	IN	_	_	_	_	_
52	fractures	_	_	NNS	_	_	_	_	_
53	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	Spain	_	_	NNP	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	prevalence	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	as	_	_	IN	_	_	_	_	_
7	determined	_	_	VBN	_	_	_	_	_
8	by	_	_	IN	_	_	_	_	_
9	densitometry	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	is	_	_	VBZ	_	_	_	_	_
12	about	_	_	RB	_	_	_	_	_
13	30	_	_	CD	_	_	_	_	_
14	%	_	_	NN	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	women	_	_	NNS	_	_	_	_	_
17	aged	_	_	VBN	_	_	_	_	_
18	50	_	_	CD	_	_	_	_	_
19	years	_	_	NNS	_	_	_	_	_
20	old	_	_	JJ	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	increasing	_	_	VBG	_	_	_	_	_
23	to	_	_	TO	_	_	_	_	_
24	50	_	_	CD	_	_	_	_	_
25	%	_	_	NN	_	_	_	_	_
26	in	_	_	IN	_	_	_	_	_
27	women	_	_	NNS	_	_	_	_	_
28	older	_	_	JJR	_	_	_	_	_
29	than	_	_	IN	_	_	_	_	_
30	70	_	_	CD	_	_	_	_	_
31	years	_	_	NNS	_	_	_	_	_
32	old	_	_	JJ	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_
34	About	_	_	RB	_	_	_	_	_
35	40	_	_	CD	_	_	_	_	_
36	%	_	_	NN	_	_	_	_	_
37	of	_	_	IN	_	_	_	_	_
38	Caucasian	_	_	JJ	_	_	_	_	_
39	women	_	_	NNS	_	_	_	_	_
40	will	_	_	MD	_	_	_	_	_
41	suffer	_	_	VB	_	_	_	_	_
42	at	_	_	IN	_	_	_	_	_
43	least	_	_	JJS	_	_	_	_	_
44	one	_	_	CD	_	_	_	_	_
45	bone	_	_	NN	_	_	_	_	_
46	fracture	_	_	NN	_	_	_	_	_
47	after	_	_	IN	_	_	_	_	_
48	their	_	_	PRP$	_	_	_	_	_
49	50s	_	_	NNS	_	_	_	_	_
50	.	_	_	.	_	_	_	_	_


1	Strategies	_	_	NNS	_	_	_	_	_
2	to	_	_	TO	_	_	_	_	_
3	minimize	_	_	VB	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	prevalence	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	disease	_	_	NN	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	its	_	_	PRP$	_	_	_	_	_
11	complications	_	_	NNS	_	_	_	_	_
12	would	_	_	MD	_	_	_	_	_
13	be	_	_	VB	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	enhance	_	_	VB	_	_	_	_	_
16	bone	_	_	NN	_	_	_	_	_
17	mass	_	_	NN	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	reduce	_	_	VB	_	_	_	_	_
20	loss	_	_	NN	_	_	_	_	_
21	at	_	_	IN	_	_	_	_	_
22	advanced	_	_	JJ	_	_	_	_	_
23	ages	_	_	NNS	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	There	_	_	EX	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	convincing	_	_	JJ	_	_	_	_	_
4	scientific	_	_	JJ	_	_	_	_	_
5	evidence	_	_	NN	_	_	_	_	_
6	supporting	_	_	VBG	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	MD	_	_	NNP	_	_	_	_	_
9	’s	_	_	POS	_	_	_	_	_
10	role	_	_	NN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	reduction	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	overall	_	_	JJ	_	_	_	_	_
16	risk	_	_	NN	_	_	_	_	_
17	for	_	_	IN	_	_	_	_	_
18	diabetes	_	_	NNS	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	cardiovascular	_	_	JJ	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	neurodegenerative	_	_	JJ	_	_	_	_	_
24	diseases	_	_	NNS	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	Regarding	_	_	VBG	_	_	_	_	_
2	site-specific	_	_	JJ	_	_	_	_	_
3	cancers	_	_	NNS	_	_	_	_	_
4	and	_	_	CC	_	_	_	_	_
5	inflammatory	_	_	JJ	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	metabolic	_	_	JJ	_	_	_	_	_
8	conditions	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	evidence	_	_	NN	_	_	_	_	_
12	is	_	_	VBZ	_	_	_	_	_
13	suggestive	_	_	JJ	_	_	_	_	_
14	or	_	_	CC	_	_	_	_	_
15	weak	_	_	JJ	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	is	_	_	VBZ	_	_	_	_	_
18	unconvincing	_	_	JJ	_	_	_	_	_
19	regarding	_	_	VBG	_	_	_	_	_
20	low-density	_	_	JJ	_	_	_	_	_
21	lipid	_	_	NN	_	_	_	_	_
22	reduction	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	MD	_	_	NNP	_	_	_	_	_
3	has	_	_	VBZ	_	_	_	_	_
4	been	_	_	VBN	_	_	_	_	_
5	shown	_	_	VBN	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	modestly	_	_	RB	_	_	_	_	_
8	reduce	_	_	VB	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	risk	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	fracture	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	is	_	_	VBZ	_	_	_	_	_
15	associated	_	_	VBN	_	_	_	_	_
16	with	_	_	IN	_	_	_	_	_
17	higher	_	_	JJR	_	_	_	_	_
18	BMD	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	Thus	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	overall	_	_	JJ	_	_	_	_	_
5	evidence	_	_	NN	_	_	_	_	_
6	points	_	_	VBZ	_	_	_	_	_
7	toward	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	role	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	MD	_	_	NNP	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	maintaining	_	_	VBG	_	_	_	_	_
15	bone	_	_	NN	_	_	_	_	_
16	health	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	especially	_	_	RB	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	postmenopausal	_	_	JJ	_	_	_	_	_
21	women	_	_	NNS	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Residual	_	_	JJ	_	_	_	_	_
2	confounding	_	_	VBG	_	_	_	_	_
3	factors	_	_	NNS	_	_	_	_	_
4	in	_	_	IN	_	_	_	_	_
5	observational	_	_	JJ	_	_	_	_	_
6	studies	_	_	NNS	_	_	_	_	_
7	has	_	_	VBZ	_	_	_	_	_
8	become	_	_	VBN	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	major	_	_	JJ	_	_	_	_	_
11	concern	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	with	_	_	IN	_	_	_	_	_
14	many	_	_	JJ	_	_	_	_	_
15	international	_	_	JJ	_	_	_	_	_
16	studies	_	_	NNS	_	_	_	_	_
17	analyzing	_	_	VBG	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	relationship	_	_	NN	_	_	_	_	_
20	between	_	_	IN	_	_	_	_	_
21	diet	_	_	NN	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	fracture	_	_	NN	_	_	_	_	_
24	risk	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	instance	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	bias	_	_	NN	_	_	_	_	_
5	should	_	_	MD	_	_	_	_	_
6	be	_	_	VB	_	_	_	_	_
7	taken	_	_	VBN	_	_	_	_	_
8	into	_	_	IN	_	_	_	_	_
9	account	_	_	NN	_	_	_	_	_
10	when	_	_	WRB	_	_	_	_	_
11	considering	_	_	VBG	_	_	_	_	_
12	meta-analysis	_	_	NN	_	_	_	_	_
13	results	_	_	NNS	_	_	_	_	_
14	on	_	_	IN	_	_	_	_	_
15	prospective	_	_	JJ	_	_	_	_	_
16	cohort	_	_	NN	_	_	_	_	_
17	studies	_	_	NNS	_	_	_	_	_
18	beyond	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	Mediterranean	_	_	JJ	_	_	_	_	_
21	region	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	due	_	_	JJ	_	_	_	_	_
4	to	_	_	TO	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	paucity	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	data	_	_	NNS	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	lack	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	consensus	_	_	NN	_	_	_	_	_
14	on	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	definition	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	MD	_	_	NNP	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	Furthermore	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	physical	_	_	JJ	_	_	_	_	_
4	activity	_	_	NN	_	_	_	_	_
5	has	_	_	VBZ	_	_	_	_	_
6	been	_	_	VBN	_	_	_	_	_
7	demonstrated	_	_	VBN	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	be	_	_	VB	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	robust	_	_	JJ	_	_	_	_	_
12	indicator	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	a	_	_	DT	_	_	_	_	_
15	lower	_	_	JJR	_	_	_	_	_
16	risk	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	bone	_	_	NN	_	_	_	_	_
19	fractures	_	_	NNS	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	Since	_	_	IN	_	_	_	_	_
2	a	_	_	DT	_	_	_	_	_
3	healthier	_	_	JJR	_	_	_	_	_
4	diet	_	_	NN	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	related	_	_	VBN	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	higher	_	_	JJR	_	_	_	_	_
9	physical	_	_	JJ	_	_	_	_	_
10	activity	_	_	NN	_	_	_	_	_
11	levels	_	_	NNS	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	latter	_	_	JJ	_	_	_	_	_
15	needs	_	_	VBZ	_	_	_	_	_
16	also	_	_	RB	_	_	_	_	_
17	to	_	_	TO	_	_	_	_	_
18	be	_	_	VB	_	_	_	_	_
19	taken	_	_	VBN	_	_	_	_	_
20	into	_	_	IN	_	_	_	_	_
21	account	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	observed	_	_	VBN	_	_	_	_	_
3	inverse	_	_	JJ	_	_	_	_	_
4	association	_	_	NN	_	_	_	_	_
5	between	_	_	IN	_	_	_	_	_
6	dietary	_	_	JJ	_	_	_	_	_
7	quality	_	_	NN	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	bone	_	_	NN	_	_	_	_	_
10	fracture	_	_	NN	_	_	_	_	_
11	risk	_	_	NN	_	_	_	_	_
12	should	_	_	MD	_	_	_	_	_
13	be	_	_	VB	_	_	_	_	_
14	interpreted	_	_	VBN	_	_	_	_	_
15	with	_	_	IN	_	_	_	_	_
16	caution	_	_	NN	_	_	_	_	_
17	because	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	case-control	_	_	JJ	_	_	_	_	_
20	design	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	most	_	_	JJS	_	_	_	_	_
23	studies	_	_	NNS	_	_	_	_	_
24	’	_	_	POS	_	_	_	_	_
25	findings	_	_	NNS	_	_	_	_	_
26	cannot	_	_	MD	_	_	_	_	_
27	indicate	_	_	VB	_	_	_	_	_
28	causality	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	There	_	_	EX	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	lack	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	research	_	_	NN	_	_	_	_	_
7	into	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	relationship	_	_	NN	_	_	_	_	_
10	between	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	MD	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	bone	_	_	NN	_	_	_	_	_
15	fracture	_	_	NN	_	_	_	_	_
16	risk	_	_	NN	_	_	_	_	_
17	that	_	_	WDT	_	_	_	_	_
18	clarifies	_	_	VBZ	_	_	_	_	_
19	causation	_	_	NN	_	_	_	_	_
20	or	_	_	CC	_	_	_	_	_
21	confounding	_	_	VBG	_	_	_	_	_
22	factors	_	_	NNS	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_

